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in multi-case families with  
non-syndromic cleft lip  
and/or palate phenotypes
Reuben J. Pengelly1, Liliana Arias2, Julio Martínez2, Rosanna Upstill-Goddard1, 
Eleanor G. Seaby1, Jane Gibson3, Sarah Ennis1, Andrew Collins1 & Ignacio Briceño2
Nonsyndromic Cleft Lip and/or Palate (NSCLP) is regarded as a multifactorial condition in which 
clefting is an isolated phenotype, distinguished from the largely monogenic, syndromic forms 
which include clefts among a spectrum of phenotypes. Nonsyndromic clefting has been shown to 
arise through complex interactions between genetic and environmental factors. However, there is 
increasing evidence that the broad NSCLP classification may include a proportion of cases showing 
familial patterns of inheritance and contain highly penetrant deleterious variation in specific genes. 
Through exome sequencing of multi-case families ascertained in Bogota, Colombia, we identify 28 non-
synonymous single nucleotide variants that are considered damaging by at least one predictive score. 
We discuss the functional impact of candidate variants identified. In one family we find a coding variant 
in the MSX1 gene which is predicted damaging by multiple scores. This variant is in exon 2, a highly 
conserved region of the gene. Previous sequencing has suggested that mutations in MSX1 may account 
for ~2% of NSCLP. Our analysis further supports evidence that a proportion of NSCLP cases arise 
through monogenic coding mutations, though further work is required to unravel the complex interplay 
of genetics and environment involved in facial clefting.
Cleft lip and/or palate (CLP) phenotypes are among the most frequent birth defects occurring at rates of 1/500–
1/2500 births1. A proportion of cases present with syndromic disease (CLP in addition to a spectrum of additional 
phenotypes) mostly caused by rare mutations in single genes that often show Mendelian patterns of inheritance. 
However up to 70% of cases show phenotypes lacking any additional cognitive or craniofacial abnormalities, 
referred to as nonsyndromic cleft lip and/or palate (NSCLP). Such phenotypes are regarded as genetically com-
plex arising through the interplay of numerous genetic and environmental factors. Increased understanding of 
the underlying aetiology of NSCLP phenotypes (both genetic and environmental) is needed to ultimately develop 
strategies for prevention, and improve treatment and prognosis. NSCLP has a significant genetic basis, for example, 
the first degree relatives of affected individuals have a 30–40 fold elevated risk and phenotype concordance for 
monozygotic (MZ) twins is 40–60%, compared to 5% for di-zygotic twins1. Genetic studies including linkage 
analysis, genome-wide association (GWAS), and GWAS-based meta-analysis, have yielded reproducible evidence 
for the involvement of several genes and gene regions. Collins et al.2, listed 16 genes and gene regions which have 
been firmly implicated in NSCLP through linkage and association analysis. Several of these are broad regions 
where the underlying causal variant(s) have yet to be pinpointed, however, polymorphisms in genes such as IRF6 
are strongly associated with NSCLP3 and more minor roles have been established for MSX14,5, PVRL1, FGFR2, 
PAX7, NOG and SPRY2 among others6.
Exome sequencing presents opportunities to identify rare coding variation that may contribute to risk of 
NSCLP phenotypes. If NSCLP is entirely multifactorial, the contribution of rarer variants may be largely poly-
genic and mediated by numerous variants of very small individual effect. In this case, causal genes may only be 
detectible through the analysis of large numbers of patients using, for example, burden tests7. However, there is 
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growing evidence for involvement of rare variants of larger effect in NSCLP including, for example, truncating 
mutations in the ARHGAP29 gene8 and mutations in the IRF6 gene, which is also known to contain mutations 
involved in malformation syndromes that include CLP such as Van der Woude9. We consider here a number of 
NSCLP families with multiple affected individuals and undertake exome sequencing to investigate the contribu-
tion of rare variants in genes previously associated with any form of clefting phenotype.
Materials and Methods
Exome sequences of twelve individuals from seven multi-case families (CL1-CL7) with NSCLP phenotypes were 
obtained. All experimental protocols were approved by the Research Ethics Committee at the Universidad de La 
Sabana, Bogota; informed consent was obtained for all participants and research was conducted in accordance 
with the Declaration of Helsinki. Families included between two and six individuals with isolated NSCLP (Fig. 1). 
Most individuals have unilateral CLP but several individuals have the more severe bilateral phenotype.
DNA samples were extracted from blood collected at Operation Smile, Bogota, Colombia and exomes were 
captured using the Agilent SureSelect v5 (51 Mb) kit and sequenced on a HiSeq 2000. Read depth coverage sta-
tistics for all 12 exome sequences are given in Supplementary Table 1, and indicate ~85–97% coverage of exon 
targets at > 20 fold depth across all samples. Orthogonal genotyping was performed for a panel of 24 SNPs to 
validate sample identity after processing10.
To understand the spectrum of potentially damaging variation, we considered the list of 865 genes previously 
implicated in any form of CLP phenotype presented by Pengelly et al.11 (Supplementary Table 2). Examining rare 
variation in genes in this comprehensive list enables evaluation of whether known CLP genes contain variation 
which may underlie more familial forms of NSCLP. Furthermore, because each exome contains a very large num-
ber of putatively damaging variants including those completely unrelated to the clefting phenotypes (including 
potential incidental findings), this strategy focussing only on genes previously implicated in any form of clefting is 
a practical route to identifying causal variation in these families. The list is derived in part (363 genes out of the 865) 
Figure 1. Pedigrees of families analysed. + symbol indicates that the individual has been exome sequenced 
(sequenced cases: two families with one family member; two families with parent and offspring; two families 
with sib pair; one family with avuncular pair).
www.nature.com/scientificreports/
3Scientific RepoRts | 6:30457 | DOI: 10.1038/srep30457
from the professional Human Gene Mutation Database12, using search terms related to clefts and clefting syn-
dromes. The remaining genes in the list were included after corresponding interrogation of OMIM13, and a small 
number of additional CLP-related genes from the review by Collins et al.2.
We filtered the lists of variants (Fig. 2) found in the exome sequences to identify all non-synonymous (NS), 
stopgain, stoploss, splicing and indel variants in genes from this list. Following Pengelly et al.11, for NS variants we 
used the scaled predictive scores from dbNSFP v214 and considered only variants classed as deleterious or damag-
ing by at least one of the following predictive metrics: PhyloP, SIFT, Polyphen2, LRT, MutationTaster and GERP+ + . 
Grantham scores were also assigned to all NS substitutions. All variants were annotated with the minor allele 
frequency (MAF) from the ExAC database15, combined CADD and Logit scores for deleteriousness, along with 
a combined overall rank developed from PhylopP, GERP+ + , CADD and Logit scores based on the summed 
ranks across all four scores such that a variant with overall rank 1 is predicted as most deleterious. For intronic 
variants within 10 bp of the exon we utilised MaxEntScan, based upon quantifying deviation from the expected 
splicing consensus sequence motif, to evaluate the likelihood of this variant affecting splicing, using a cutoff of a 
differential score of 316.
We excluded variants found in homopolymer/repeat regions that can arise through misalignment between 
the sequenced reads and reference sequence. Any variants with read depth of < 10 or in genes considered to be 
‘highly mutable’17 were removed from further consideration. We included all variants not previously listed in the 
following databases: dbSNP 13518, 1000 genomes19, the exome variant server20 and our in-house database of ~300 
exomes, but did not exclude variants present solely at low frequency in the ExAC database15. In Tables 1 & 2 we 
included only variants found in all exome-sequenced, affected, family members but not shared by more than one 
family; this was to exclude variants potentially common to the region not captured in the population resequenc-
ing projects. Because samples were not available for all family members, it was not possible to confirm segregation 
of putatively causal variants for all affected individuals. All variants presented in text were manually visualised to 
evaluate genotype quality in the raw alignment files using IGV21, and no features consistent with errors were pres-
ent yielding high-confidence genotype calls. The full list of rare (< 1% in 1000 Genomes) NS variants classed as 
damaging by at least one predictive score and potentially damaging splicing variants are given in Supplementary 
Table 3. Whole-exome genotype calls are provided in Supplementary File 4.
Results
Table 1 shows likely protein truncating and indel variants in these seven families, with Table 2 listing 28 missense 
variants. For a given family only variants found for all the exome-sequenced family members (Fig. 1) and classed 
as deleterious by at least one predictive score is given. Table 2 entries are ordered using combined ranks from 
most to least deleterious by predictive score11. Four of the genes listed in Table 2 (WNT7A, MSX1, CLPTM1 and 
EVC2, ranked 9, 10, 11 and 23 respectively) have been previously identified as containing variants implicated in 
NSCLP phenotypes. Family CL1 has the 9th ranked variant in the WNT7A gene. Members of the WNT gene fam-
ily have previously been associated with NSCLP phenotypes22–24. Specifically, a number of WNT signalling path-
way genes including WNT3A, WNT5A, WNT9B, and WNT11 have been established as candidates22 and mouse 
expression studies have shown roles for WNT genes in mid-facial formation and lip and palate development25.
The 10th ranked variant, found in family CL4, is in the MSX1 gene, and considered damaging by SIFT, 
PolyPhen-2 and MutationTaster and has high GERP+ + and CADD scores. Variants in this gene have been 
strongly implicated in NSCLP in several studies. Jezewski et al.26 found mutations in 2% of CLP cases and indi-
cated that this has genetic counselling implications where autosomal dominant inheritance patterns are found. 
Exon 2 of MSX1, in which the p.P260T is located, has been found to be highly conserved with significantly fewer 
sequence variants compared with exon 1 of this small (two exon) gene26. Functional validation of MSX1 as a can-
didate is established through a cleft palate and foreshortened maxilla phenotype in knockout mice27. A number 
of association studies have also indicated involvement of MSX1 in NSCLP4,28–31. In a study of 94 patients and 93 
controls from Operation Smile, Colombia, four MSX1 microsatellite alleles were analysed and an increased risk 
of CLP was observed with CA polymorphisms in the gene32. An autosomal dominant MSX1 mutation in a family 
with clefting and tooth agenesis showed a familial pattern of segregating MSX1 mutations5. Diverse evidence 
establishes that MSX1 promotes growth and inhibits differentiation. Mutations in MSX1 can cause primary or 
secondary facial clefting in mouse models26.
The 11th ranked variant (from family CL1) is in the CLPTM1 gene (Cleft lip-and palate-associated transmem-
brane protein-1) which is situated at 19q13.3. A balanced translocation is this region was found in a multi-case 
CLP family33 and this region is implicated in NSCLP by linkage and transmission disequilibrium test associa-
tion studies34. However a de novo deletion of 0.8 Mb in this region associated with CLP, but not encompassing 
CLPTM1, has been reported35. As Kohli and Kohli36 indicate, the role of CLPTM1 or other genes in this locus is 
uncertain.
The 23rd ranked variant is in the EVC2 gene (family CL2) and belongs to the same two megabase chromosomal 
region as MSX1 (4p16). Ingersoll et al.37 found linkage and association signals in genes in this region. They found 
suggestive evidence for linkage and association amongst cleft palate trios to EVC2. Mutations in EVC2 can lead to 
Weyers acrofacial dysostosis38, not usually associated with oral clefts but cases with subtle CLP phenotypes, and 
tooth anomalies have been reported37.
Discussion
Linkage, candidate gene association and genome-wide association (GWAS) have been applied to investigate 
numerous multifactorial diseases, including NSCLP. As a result of these studies more than 11 genes and gene 
regions are now known or likely to have an etiologic role in NSCLP39. However, there is increasing evidence 
that NSCLP is a heterogeneous condition comprising a substantial multifactorial component along with a much 
smaller proportion of cases showing more Mendelian patterns of inheritance. The Gajdos et al.40 segregation 
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Figure 2. Variant filtering process. Variants identified in patients were filtered as described in methods. 
Variant attrition at each step is shown here, with variants remaining after sequential filtering detailed in square 
brackets.
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analysis indicated that the complex familial patterns observed in NSCLP is best explained as a mixture of mono-
genic cases, probably dominantly inherited, combined with others which have a multifactorial aetiology. The 
conclusions favour analyses of multiple-case pedigrees to reduce heterogeneity and help identify Mendelian 
sub-forms. Stanier and Moore41 identified significant overlaps between genes underlying syndromic and nonsyn-
dromic forms of CLP, recognising that several genes implicated in syndromic disease, including TBX22, PVRL1, 
IRF6, P63 and MSX1, can also contribute to ~10% of NSCLP. Scapoli et al.42 point out that the autosomal dom-
inant Van der Woude syndrome (VWS) is only phenotypically distinguished from NSCLP by lower-lip pits and 
hypodontia which are only variably present in VWS affected individuals. Mutations in the IRF6 gene, which cause 
VWS, have been firmly implicated in some NSCLP cases3 supporting heterogeneity with the NSCLP clinical 
designation. Furthermore, Kerameddin et al.43 found a tag SNP (rs642961) in IRF6 was associated with the most 
severe complete bilateral NSCLP phenotype. This suggests multi-case families with bilateral clefts are the most 
Gene
Genomic 
Position Transcript ID Exon mRNA change Protein change Variant type
ExAC 
MAF ΔMaxEnt CL1 CL2 CL3 CL4 CL5 CL6 CL7
DLG1 3:196846393 NM_001204388 8 923_925del 308_309del nonframeshift_deletion - . ◊ 
FRAS1 4:79391228 NM_025074 51 G7354T E2452X stopgain - . ◊ 
WDR11 10:122660583 NM_018117 21 2660_2662del 887_888del nonframeshift_deletion - . ◊ 
IGF1R 15:99500507 NM_000875 21 3940_3941insCGTCCTCCC L1314delinsPSSL nonframeshift_insertion - . ◊ 
FBLN1 22:45927140 NM_001996 5 485-5C> - splicing - 22 ◊ 
Table 1.  Protein truncating, splicing and indel variants observed in single families. ◊ = Heterozygous 
variant observed for all family members sequenced.
Gene
Genomic 
Position Transcript ID Exon
mRNA 
change
Protein 
change
ExAC 
MAF SIFT
Poly 
Phen-2
Mutation 
Taster
Grantham 
score PhyloP GERP++ CADD Logit Rank CL1 CL2 CL3 CL4 CL5 CL6 CL7
WDR35 2:20137643 NM_001006657 20 C2161T R721C 4.1E-05 0.00 0.92 1.00 180 9.81 5.04 27.70 0.13 1 ◊ 
PTHLH 12:28122357 NM_002820 3 G71A G24E - 0.00 1.00 0.99 98 5.75 5.13 32.00 0.39 2 ◊ 
GPC6 13:94482686 NM_005708 3 T599A F200Y - 0.00 0.98 0.95 22 7.65 5.48 31.00 0.06 3 ◊ 
INPPL1 11:71939494 NM_001567 3 G349A V117I - 0.00 0.95 0.04 29 8.18 3.90 22.80 0.11 4 ◊ 
MYH3 17:10539158 NM_002470 29 G3869A R1290H 3.3E-05 0.00 0.10 0.94 29 4.95 4.84 21.30 0.13 5 ◊ 
AHDC1 1:27876631 NM_001029882 6 C1996G R666G 8.6E-06 0.00 1.00 0.06 125 8.73 5.08 22.80 0.04 6 ◊ 
ABCA12 2:215928852 NM_173076 3 C254T T85I - 0.99 0.73 0.00 89 4.18 5.30 15.26 0.10 7 ◊ 
DEAF1 11:654023 NM_021008 11 C1532G A511G - 0.00 0.59 1.00 60 9.01 3.03 17.71 0.08 8 ◊ 
WNT7A 3:13860472 NM_004625 4 G1019A S340N - 0.00 0.94 0.99 46 6.07 4.11 23.60 0.06 9 ◊ 
MSX1 4:4864736 NM_002448 2 C778A P260T 1.3E-04 0.00 0.61 0.99 38 5.96 4.76 27.60 0.04 10 ◊ 
CLPTM1 19:45491357 NM_001294 9 A1058G N353S 8.2E-06 0.04 0.60 0.99 46 6.60 3.01 17.19 0.09 11 ◊ 
IGF1R 15:99500597 NM_000875 21 C4030G Q1344E - 0.00 0.01 0.99 29 4.78 5.24 13.05 0.04 12 ◊ 
CFDP1 16:75429103 NM_006324 5 A535T T179S - 0.00 0.02 0.99 58 2.66 5.54 15.68 0.04 13 ◊ 
NBAS 2:15651437 NM_015909 10 G784A G262S - 0.01 0.09 0.86 56 4.26 4.15 13.81 0.07 14 ◊ 
COL17A1 10:105795306 NM_000494 49 T3434C I1145T 1.9E-05 0.00 0.15 0.31 89 5.46 4.39 12.18 0.06 15 ◊ 
CDON 11:125887051 NM_001243597 6 A860G N287S - 0.00 0.34 0.64 46 3.10 5.01 15.32 0.04 16 ◊ 
SNAP29 22:21224814 NM_004782 2 A427G N143D - 0.02 0.34 0.17 23 8.77 3.70 11.41 0.04 17 ◊ 
NOTCH2 1:120509101 NM_001200001 9 G1465T V489L - 0.00 0.08 0.34 32 0.87 5.38 12.51 0.05 18 ◊ 
MASP1 3:186937872 NM_001879 16 G2087A G696E 1.7E-05 0.05 0.09 0.37 98 1.65 3.75 14.53 0.06 19 ◊ 
FREM2 13:39263993 NM_207361 1 A2512G T838A 8.2E-06 0.00 0.00 1.00 58 2.49 4.44 7.38 0.07 20 ◊ 
SPRY4 5:141693887 NM_030964 3 C856T R286C 2.5E-05 0.00 0.88 0.97 180 2.44 4.70 13.49 0.04 21 ◊ 
ZBTB24 6:109802863 NM_001164313 2 A367G K123E - 0.00 0.05 0.32 56 1.52 4.16 14.67 0.03 22 ◊ 
EVC2 4:5617202 NM_001166136 16 G2536A E846K 1.6E-05 0.10 0.67 0.27 56 1.14 2.85 16.13 0.03 23 ◊ 
SCN2A 2:166187894 NM_001040143 13 T2204C M735T - 0.04 0.00 0.06 81 0.47 2.35 2.95 0.04 24 ◊ 
RYR1 19:38976754 NM_000540 34 G5459T R1820L - 0.04 0.01 0.71 102 0.93 1.71 8.87 0.03 25 ◊ 
WT1 11:32456755 NM_024426 1 C137T A46V - 0.02 0.00 0.00 64 0.33 0.81 12.21 0.02 26 ◊ 
INPPL1 11:71949096 NM_001567 27 T3563G L1188R 1.0E-05 0.10 . 0.01 102 0.44 1.47 10.20 0.01 27 ◊ 
COL6A2 21:47551876 NM_001849 28 G2470A V824M 2.9E-04 0.00 . 1.00 21 . 3.62 . . - ◊ 
Table 2.  Non-synonymous variants observed in single families. ◊ = Heterozygous variant observed for all 
family members sequenced. Underlined predictive scores damaging by at least one of: SIFT < 0.05 (variant 
considered to affect protein function); PolyPhen-2 HumVar scores > 0.447 (variant possibly damaging) 
and > = 0.909 (variant probably damaging); MutationTaster scores > 0.95 (variant considered damaging); 
Grantham scores > 100 (radical amino acid change).
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likely to be segregating single gene mutations. This strategy is supported by Vieira et al.44 who indicate that point 
mutations in several genes contribute to ~6% of NSCLP, and these are enriched in cases with bilateral clefting.
In Table 2, we identify a coding variant in the MSX1 gene shared by affected family members in CL4 in which 
the proband has a bilateral CLP phenotype. Direct sequencing of coding regions has shown rare mutations in 
MSX1 may account for ~2% of NSCLP. The identified MSX1 variant is present at low frequency in the ExAC 
database (Table 2). ExAC contains > 60,000 exomes from various disease specfic and population genetic studies 
(http://exac.broadinstitute.org/). Functional studies and analyses of larger cohorts of multi-case NSCLP families 
are required to establish a possible role for this and other rare variants identified in NSCLP phenotypes. Variants 
identified here also include candidates in the WNT7A (family CL1) ,CLPTM1 (family CL1) and EVC2 genes 
(family CL2) which should be considered as targets for analysis in additional families.
For investigations aiming to resolve the genetic factors underlying NSCLP in multiple case families, exome 
sequencing presents a relatively cost-effective approach in which sequencing a small number of affected family 
members can identify candidate underlying genetic variation. NSCLP provides a particular challenge for genetic 
studies, with incomplete penetrance and environmental factors hindering the identification of aetiological var-
iance2,39. We have aimed to minimise this effect by careful selection of pedigrees exhibiting clefting in multiple 
individuals, where we would expect a stronger genetic component. Filtering power would be increased by the 
inclusion of further members of the pedigrees, however this has not been viable due to the isolated geographic 
locations for many individuals.
Exome sequencing yields thousands of variants per individual and identification of candidate variants can 
only be achieved following extensive filtering. We have undertaken filtering to identify variants predicted as 
damaging by restricting analysis to a list of 865 genes which have been previously associated with any condition 
involving CLP. Such an approach risks missing causal variants in novel genes not previously linked to NSCLP, 
but facilitates practicable data interpretation by virtue of the greater prior probability that they are associated 
with NSCLP. The composite score based rank using PhyloP, GERP+ + . CADD and logit (Table 2) has been used 
successfully prioritise variants involved in syndromic CLP11, These four scores are closely correlated, although the 
composite measures are not independent in every case. Further improvements in predictive tools and recognition 
of more disease variants and understanding of disease pathways will enable future improvements in interpreta-
tion of these complex data sets.
Whilst predictive tools are essential for the prioritisation of variants discovered in next generation sequencing 
(NGS) studies, ultimately functional validation of the effects of variants on protein function is required to confirm 
their impact. Given the volume of potentially pathogenic variants being identified in NGS studies, routine func-
tional validation is infeasible. In silico protein modelling approaches may also be used to improve throughput, 
however these require the prior determination of protein structure, which has not been reported in the majority 
of genes discussed herein. Overall, it is clear that functional validation is a significant bottleneck in NGS studies, 
and one not readily assuaged.
The limitations of exome sequencing include lack of coverage outside gene coding regions thereby excluding 
regulatory variants, which may influence risk. Technical limitations include poor coverage of some coding regions 
thereby missing potential causal variants. Whole genome sequencing offers a solution to these coverage issues, 
but at higher cost and considerably increased analytical complexity. Given the extent of the missing heritability in 
CLP, it is likely non-coding regions of the genome play a significant role; whole genome sequencing may therefore 
provide a valuable tool as sequencing costs continue to drop.
In this study we have limited our analyses to 865 genes with a known/suspected involvement in CLP pheno-
types. Whilst this will prevent us from identifying novel aetiological genes, 7 families would be underpowered to 
identify novel causal genes reliably. Large cohort studies are required in order to identify novel CLP genes; to this 
end we have made our WES data available in Supplementary File 4 for the use of other researchers.
In conclusion, we have undertaken exome analysis in seven Colombian families with NSCLP phenotypes. We 
find a deleterious variant in the MSX1 gene in family CL4 which is a strong candidate for causality. Deleterious 
variants in at least three additional genes may be implicated in NSCLP phenotypes in some of the other families. 
Although NSCLP is primarily a complex multifactorial phenotype, our study adds to the growing body of evi-
dence that Mendelian sub-forms exist and these are best studied in multi-case families particularly where there 
are more severe phenotypic features such as bilateral clefting.
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